Judge Reverses Precedex Patent Invalidation Following Deal

Law360, Los Angeles (February 27, 2014, 8:42 PM ET) -- A New Jersey federal judge on Thursday vacated an order invalidating one of the patents asserted in Hospira Inc.'s suit challenging a bid by Sandoz Inc. for approval of a generic version of Precedex, following a settlement recently reached between the parties.

The deal, struck this past December, permits Sandoz to launch its generic version of the sedative next December.

The complaint, first filed in 2009, accuses the company of violating Hospira and Finland-based Orion Corp.’s jointly owned U.S. Patent No. 6,716,867 — the patent-at-issue in...
To view the full article, register now.